Advertisement Agilent acquires BioSystem Development Business - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Agilent acquires BioSystem Development Business

Agilent Technologies has acquired BioSystem Development business that specializes in developing and manufacturing the AssayMAP Microchromatography platform.

BioSystem Development’s AssayMAP platform, based on disposable microchromatography cartridges, enables for the first time, automation of complex, multi-step sample preparation workflows.

They include protein purification, characterization and analysis solutions for bioprocess development, biomarker identification and analysis, besides other life science research applications.

According to the company, the need for automated, quality protein sample preparation and analysis has become critical.

The collaboration combines AssayMAP technology with Agilent’s automated liquid handling platforms, to reduce discovery and development time and increase lab efficiency.

Financial details of the transaction have not been revealed.